These drugs are effective only while active in your system, and stopping treatment allows hunger and fullness signals to revert to their pre-treatment state
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Healthcare providers evaluate progress individually rather than expecting all patients to follow the same timeline or achieve identical outcomes
After her second, she started walking three miles per day, her anaphylaxis attacks improved, and her further pruritus, flushing, diarrhea, or post-prandial abdominal pain disappeared, and she regained tolerance for previously intolerable foods
For others, with milder or temporary deficiencies, the initial shots might lead to longer periods of feeling well, potentially even allowing for a switch to oral supplements under strict medical guidance
